These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15184704

  • 1. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder.
    Girdler SS, Thompson KS, Light KC, Leserman J, Pedersen CA, Prange AJ.
    Psychosom Med; 2004; 66(3):403-10. PubMed ID: 15184704
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-thyroid axis function in women with a menstrually related mood disorder: association with histories of sexual abuse.
    Bunevicius A, Leserman J, Girdler SS.
    Psychosom Med; 2012 Oct; 74(8):810-6. PubMed ID: 23001392
    [Abstract] [Full Text] [Related]

  • 3. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls.
    Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA, Pedersen CA, Light KC.
    Psychosom Med; 2003 Oct; 65(5):849-56. PubMed ID: 14508031
    [Abstract] [Full Text] [Related]

  • 4. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL.
    Biol Psychiatry; 2001 May 01; 49(9):788-97. PubMed ID: 11331087
    [Abstract] [Full Text] [Related]

  • 5. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
    Beddig T, Reinhard I, Kuehner C.
    Psychoneuroendocrinology; 2019 Nov 01; 109():104372. PubMed ID: 31357135
    [Abstract] [Full Text] [Related]

  • 6. Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation.
    Barone JC, Ho A, Osborne LM, Eisenlohr-Moul TA, Morrow AL, Payne JL, Epperson CN, Hantsoo L.
    Psychoneuroendocrinology; 2024 Nov 01; 169():107145. PubMed ID: 39096755
    [Abstract] [Full Text] [Related]

  • 7. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
    Reed SC, Levin FR, Evans SM.
    Horm Behav; 2008 Jun 01; 54(1):185-93. PubMed ID: 18413151
    [Abstract] [Full Text] [Related]

  • 8. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
    Segebladh B, Bannbers E, Moby L, Nyberg S, Bixo M, Bäckström T, Sundström Poromaa I.
    Arch Womens Ment Health; 2013 Apr 01; 16(2):131-7. PubMed ID: 23329007
    [Abstract] [Full Text] [Related]

  • 9. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.
    Bunevicius R, Hinderliter AL, Light KC, Leserman J, Pedersen CA, Girdler SS.
    Biol Psychol; 2005 Jul 01; 69(3):281-96. PubMed ID: 15925031
    [Abstract] [Full Text] [Related]

  • 10. Altered binding of serum thyroid hormone to thyroxine-binding globulin in women with functional hypothalamic amenorrhea.
    Dominguez CE, Laughlin GA, Nelson JC, Yen SS.
    Fertil Steril; 1997 Dec 01; 68(6):992-6. PubMed ID: 9418685
    [Abstract] [Full Text] [Related]

  • 11. Thyroid axis function during the menstrual cycle in women with premenstrual syndrome.
    Girdler SS, Pedersen CA, Light KC.
    Psychoneuroendocrinology; 1995 Dec 01; 20(4):395-403. PubMed ID: 8532823
    [Abstract] [Full Text] [Related]

  • 12. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH.
    Arch Gen Psychiatry; 2002 Sep 01; 59(9):851-8. PubMed ID: 12215085
    [Abstract] [Full Text] [Related]

  • 13. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E, Kirkan TS, Yildirim A, Kotan Z, Cansever Z, Ozcan H, Aliyev E, Gulec M.
    Gen Hosp Psychiatry; 2015 Sep 01; 37(3):266-72. PubMed ID: 25799087
    [Abstract] [Full Text] [Related]

  • 14. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN, Yonkers KA, Phan SP, Blakeley JE, Williams A, Rush AJ.
    Biol Psychiatry; 1998 Oct 01; 44(7):600-9. PubMed ID: 9787884
    [Abstract] [Full Text] [Related]

  • 15. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.
    Yen JY, Lin PC, Huang MF, Chou WP, Long CY, Ko CH.
    Int J Environ Res Public Health; 2020 Feb 05; 17(3):. PubMed ID: 32033286
    [Abstract] [Full Text] [Related]

  • 16. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder.
    Straneva PA, Maixner W, Light KC, Pedersen CA, Costello NL, Girdler SS.
    Health Psychol; 2002 Jul 05; 21(4):358-67. PubMed ID: 12090678
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.
    Le Mellédo JM, Merani S, Koszycki D, Bellavance F, Palmour R, Gutkowska J, Steinberg S, Bichet DG, Bradwejn J.
    Neuropsychopharmacology; 1999 Jan 05; 20(1):81-91. PubMed ID: 9885787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder.
    Girdler SS, Pedersen CA, Straneva PA, Leserman J, Stanwyck CL, Benjamin S, Light KC.
    Psychiatry Res; 1998 Nov 16; 81(2):163-78. PubMed ID: 9858034
    [Abstract] [Full Text] [Related]

  • 20. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy.
    Baumgartner A, von Stuckrad M, Müller-Oerlinghausen B, Gräf KJ, Kürten I.
    J Affect Disord; 1995 Jun 08; 34(3):211-8. PubMed ID: 7560549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.